Citius Pharmaceuticals is trading at $0.65, up +11.97%, alongside stronger market sentiment.
- The Nasdaq is up 1.40% and the S&P 500 is up 0.63%.
- No fresh company-specific announcement was identified for August 27, 2026; the latest major company news was fiscal third-quarter results released August 14, 2026.
- H.C. Wainwright reiterated its Buy rating on August 27, but that recommendation was originally reported earlier.